Safety of a fifth dose of diphtheria and tetanus toxoid and acellular pertussis vaccine in children experiencing extensive, local reactions to the fourth dose

Pediatric Infectious Disease Journal

Volumn 27, Issue 5, 2008, Pages 464-465

  Rennels, Margaret B ^a   Black, Steven ^b   Woo, Emily Jane ^c   Campbell, Scott ^d   Edwards, Kathryn M ^e,f  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e VANDERBILT UNIVERSITY   (United States)

^f VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

DTaP; revaccination; safety; swelling

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ANTIBODY TITER; ARM SWELLING; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; IMMUNIZATION; PRIORITY JOURNAL; PRURITUS; REVACCINATION; SKIN REDNESS; ARM; PATHOLOGY; PRESCHOOL CHILD;

ARM; CHILD; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; HUMANS; IMMUNIZATION, SECONDARY;

EID: 45849086194     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31816591f7     Document Type: Article

References (8)

1. Schmitt H-J, Beutel K, Schuind A, et al. Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age. J Pediatr. 1997;130:616-623.
2. Meade BD, Deforest A, Edwards KM, et al. Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines. Pediatrics 1995;96:570 -575.
3. Rennels MB, Deloria MA, Pichichero ME, et al. Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines. Pediatrics 2000;105:e12.
4. Jackson LA, Starkovich P, Froeschle J, et al. Prospective assessment of the safety of the fifth consecutive dose of Tripedia DTaP vaccine. Abstr Gen Meet Am Soc Microbiol 2002;42:Abstract G-1215.
5. Jackson LA, Dunstan M, Starkovich P, et al. Prophylaxis with acetaminophen or ibuprofen for prevention of local reactions to the fifth diphtheriatetanus toxoids-acellular pertussis vaccination: a randomized, controlled trial. Pediatrics. 2006;117:620-625.
6. Jackson LA, Carste BA, Malais D, Froeschle J. Retrospective populationbased assessment of medically attended injection site reactions, seizures, allergic responses and febrile episodes after acellular pertussis vaccine combined with diphtheria and tetanus toxoids. Pediatr Infect Dis J. 2002;21:781-786.
7. Pichichero ME, Edwards KM, Anderson EL, et al. Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children. Pediatrics. 2000;105:e11.
8. Liese JG, Stojanov S, Zink TH, et al. Safety and immunogenicity of Biken acellular pertussis vaccine in combination with diphtheria and tetanus toxoid as a fifth dose at four to six years of age. Pediatr Infect Dis J. 2001;20:981-988.